Back to Journals » OncoTargets and Therapy » Volume 7

Brentuximab vedotin for relapsed or refractory CD30+ Hodgkin lymphoma: a multicenter analysis from Asia

Total article views   Abstract views HTML views PDF downloads Totals
6,564 Dovepress* 4,637 1,219+ 1,124 5,856
PubMed Central* 0 708 340 708
Totals 4,637 1,927 1,464 6,564
*Since 26 September 2014
+Since July 2016

View citations on PubMed Central and Google Scholar